I 
117TH CONGRESS 
2D SESSION 
H. R. 6512 
To repeal the authority of the Food and Drug Administration to require 
that drugs be dispensed only upon prescription, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 28, 2022 
Mr. BIGGS introduced the following bill; which was referred to the Committee 
on Energy and Commerce 
A BILL 
To repeal the authority of the Food and Drug Administration 
to require that drugs be dispensed only upon prescrip-
tion, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Prescription Freedom 
4
Act of 2022’’. 
5
SEC. 2. REPEAL OF FDA AUTHORITY TO REQUIRE PRE-
6
SCRIPTIONS. 
7
(a) REPEAL.—Effective as of the date that is 6 
8
months after the date of enactment of this Act, subsection 
9
VerDate Sep 11 2014 
22:49 Jan 28, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6512.IH
H6512
pbinns on DSKJLVW7X2PROD with BILLS
2 
•HR 6512 IH
(b) of section 503 of the Federal Food, Drug, and Cos-
1
metic Act (21 U.S.C. 353) is repealed. 
2
(b) REFERENCES.—Beginning on the effective date 
3
described in subsection (a), any reference in a Federal 
4
statute, regulation, or guidance— 
5
(1) to prescribing, a prescription, a prescription 
6
drug, or a drug subject to section 503(b) of the Fed-
7
eral Food, Drug, and Cosmetic Act is deemed to be 
8
a reference to prescribing, a prescription, or a pre-
9
scription drug, respectively, under applicable State 
10
law; and 
11
(2) to any requirement or provision of section 
12
503(b) of the Federal Food, Drug, and Cosmetic Act 
13
is deemed to be a reference to the corresponding re-
14
quirement or provision, if any, in applicable State 
15
law, as determined by the Federal official or officials 
16
responsible for administering the respective Federal 
17
statute, regulation, or guidance. 
18
(c) EXCEPTION.—Notwithstanding subsections (a) 
19
and (b), the Secretary of Health and Human Services may 
20
continue to exercise the authority vested by subsection (b) 
21
of section 503 of the Federal Food, Drug, and Cosmetic 
22
Act (21 U.S.C. 353), as in effect on the day before the 
23
effective date described in subsection (a), with respect to 
24
VerDate Sep 11 2014 
22:49 Jan 28, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6512.IH
H6512
pbinns on DSKJLVW7X2PROD with BILLS
3 
•HR 6512 IH
any drug that is intended for use in terminating a preg-
1
nancy. 
2
Æ 
VerDate Sep 11 2014 
22:49 Jan 28, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6512.IH
H6512
pbinns on DSKJLVW7X2PROD with BILLS
